Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,382,313
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
9,407,022
-
Shares change
-
-454,923
-
Total reported value, excl. options
-
$26,340,000
-
Value change
-
-$1,500,189
-
Number of buys
-
12
-
Number of sells
-
11
-
Price
-
$2.80
Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) as of Q1 2022
As of 31 Mar 2022 TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) had 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,407,022 shares of stock of the company.
Largest 10 holders included BlackRock Inc., BAKER BROS. ADVISORS LP, Deer Management Co. LLC, Alphabet Inc., RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., DC Funds, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, and Tekla Capital Management LLC.
This table shows 24 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.